Your browser doesn't support javascript.
loading
Strong peak immunogenicity but rapid antibody waning following third vaccine dose in older residents of care homes.
Tut, Gokhan; Lancaster, Tara; Krutikov, Maria; Sylla, Panagiota; Bone, David; Spalkova, Eliska; Bentley, Christopher; Amin, Umayr; Jadir, Azar; Hulme, Samuel; Kaur, Nayandeep; Tut, Elif; Bruton, Rachel; Wu, Mary Y; Harvey, Ruth; Carr, Edward J; Beale, Rupert; Stirrup, Oliver; Shrotri, Madhumita; Azmi, Borscha; Fuller, Christopher; Baynton, Verity; Irwin-Singer, Aidan; Hayward, Andrew; Copas, Andrew; Shallcross, Laura; Moss, Paul.
Afiliación
  • Tut G; Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, UK.
  • Lancaster T; Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, UK.
  • Krutikov M; UCL Institute of Health Informatics, London, UK.
  • Sylla P; Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, UK.
  • Bone D; Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, UK.
  • Spalkova E; Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, UK.
  • Bentley C; Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, UK.
  • Amin U; Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, UK.
  • Jadir A; Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, UK.
  • Hulme S; Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, UK.
  • Kaur N; Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, UK.
  • Tut E; Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, UK.
  • Bruton R; Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, UK.
  • Wu MY; Covid Surveillance Unit, The Francis Crick Institute, London, UK.
  • Harvey R; Worldwide Influenza Centre, The Francis Crick Institute London, London, UK.
  • Carr EJ; The Francis Crick Institute, London, UK.
  • Beale R; The Francis Crick Institute, London, UK.
  • Stirrup O; Genotype-to-Phenotype UK National Virology Consortium (G2P-UK), London, UK.
  • Shrotri M; UCL Department of Renal Medicine, Royal Free Hospital, London, UK.
  • Azmi B; Health Security Agency, London, UK.
  • Fuller C; UCL Institute of Health Informatics, London, UK.
  • Baynton V; UCL Institute of Health Informatics, London, UK.
  • Irwin-Singer A; UCL Institute of Health Informatics, London, UK.
  • Hayward A; Health Security Agency, London, UK.
  • Copas A; Health Security Agency, London, UK.
  • Shallcross L; Health Data Research UK, London, UK.
  • Moss P; UCL Institute for Global Health, London, UK.
Nat Aging ; 3(1): 93-104, 2023 01.
Article en En | MEDLINE | ID: mdl-37118525
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Vacunas / COVID-19 Tipo de estudio: Observational_studies Límite: Aged / Humans Idioma: En Revista: Nat Aging Año: 2023 Tipo del documento: Article País de afiliación: Reino Unido
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Vacunas / COVID-19 Tipo de estudio: Observational_studies Límite: Aged / Humans Idioma: En Revista: Nat Aging Año: 2023 Tipo del documento: Article País de afiliación: Reino Unido